Literature DB >> 15252653

DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.

Craig R Brodie1, J Grant Collins, Janice R Aldrich-Wright.   

Abstract

This study documents the first detailed investigation into the relationship between molecular structure and biological activity of platinum(II) complexes containing methylated derivatives of 1,10-phenanthroline (phen). A series of square planar platinum(II) compounds incorporating methylated derivatives of phen, 4-methyl-1,10-phenanthroline (4-Mephen), 5-methyl-1,10-phenanthroline (5-Mephen), 4,7-dimethyl-1,10-phenanthroline (4,7-Me2phen), 5,6-dimethyl-1,10-phenanthroline (5,6-Me2phen) and 3,4,7,8-tetramethyl-1,10-phenanthroline (3,4,7,8-Me4phen) were synthesised and the relationship between their structure and biological activity investigated. The biological activity of these compounds was quantified using the in vitro cytotoxicity assay against the L1210 Murine leukaemia cell line. Large variation in cytotoxicities with different methylation was observed. The 5- and 5,6-methylated derivatives of phen displayed a greater biological activity, with IC50 values of 2.8 +/- 0.8 microM and 1.5 +/- 0.3 microM respectively, compared with the phen compound, with an IC50 value of 9.7 +/- 0.3 microM, while all the others were inactive with IC50 values over 50 microM. Binding constants were determined using circular dichroism spectroscopy (CD) and induced circular dichroism (ICD). ICD was used to highlight any differences in the spectra. Viscometry studies and linear dichroism (LD) experiments indicate that the platinum(II) complexes intercalate although for [Pt(en)(4-Mephen)]Cl2 and [Pt(en)(4,7-Me2phen)]Cl2 this mode of binding appears to be concentration dependent. The binding of the platinum(II) complexes to the oligonucleotide d(GTCGAC)2 was studied using two-dimensional 1H NMR spectroscopy. The addition of each metal complex to the hexamer d(GTCGAC)2 produced upfield shifts of the metal complex resonances, characteristic of intercalation. Through the observation of NOE cross-peaks, two-dimensional NMR studies provided insight into the site and groove preferences of these compounds when binding to DNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252653     DOI: 10.1039/b316511f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  16 in total

1.  Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.

Authors:  Johnny Moretto; Bruno Chauffert; François Ghiringhelli; Janice R Aldrich-Wright; Florence Bouyer
Journal:  Invest New Drugs       Date:  2010-06-10       Impact factor: 3.850

2.  A study of Pt(II)-phenanthroline complex interactions with double-stranded and G-quadruplex DNA by ESI-MS, circular dichroism, and computational docking.

Authors:  Dale L Ang; Celine Kelso; Jennifer L Beck; Stephen F Ralph; David G Harman; Janice R Aldrich-Wright
Journal:  J Biol Inorg Chem       Date:  2020-03-26       Impact factor: 3.358

3.  DNA binding and unwinding by self-assembled supramolecular hetero-bimetallacycles.

Authors:  Anurag Mishra; Sambandam Ravikumar; Soon Ho Hong; Hyunuk Kim; Vaishali Vajpayee; Hyewoo Lee; Byungchan Ahn; Ming Wang; Peter J Stang; Ki-Whan Chi
Journal:  Organometallics       Date:  2011-11-14       Impact factor: 3.876

Review 4.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

5.  Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts.

Authors:  Yvonne Geldmacher; Katrin Splith; Igor Kitanovic; Hamed Alborzinia; Suzan Can; Riccardo Rubbiani; M Ali Nazif; Pascal Wefelmeier; Aram Prokop; Ingo Ott; Stefan Wölfl; Ines Neundorf; William S Sheldrick
Journal:  J Biol Inorg Chem       Date:  2012-02-23       Impact factor: 3.358

6.  Identification of the molecular mechanisms underlying the cytotoxic action of a potent platinum metallointercalator.

Authors:  Shaoyu Wang; Vincent J Higgins; Janice R Aldrich-Wright; Ming J Wu
Journal:  J Chem Biol       Date:  2011-12-06

7.  A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDI(QQ))]Cl.

Authors:  Kogularamanan Suntharalingam; Justin J Wilson; Wei Lin; Stephen J Lippard
Journal:  Metallomics       Date:  2014-02-11       Impact factor: 4.526

8.  Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.

Authors:  Sharon Kemp; Nial J Wheate; Shaoyu Wang; J Grant Collins; Stephen F Ralph; Anthony I Day; Vincent J Higgins; Janice R Aldrich-Wright
Journal:  J Biol Inorg Chem       Date:  2007-07-25       Impact factor: 3.358

9.  Spectroscopic investigations on the interactions of potent platinum(II) anticancer agents with bovine serum albumin.

Authors:  Anwen M Krause-Heuer; William S Price; Janice R Aldrich-Wright
Journal:  J Chem Biol       Date:  2012-05-11

10.  Synthesis and Evaluation of the Cytotoxic Activity of Water-Soluble Cationic Organometallic Complexes of the Type [Pt(η1-C2H4OMe)(L)(Phen)]+ (L = NH3, DMSO; Phen = 1,10-Phenanthroline).

Authors:  Federica De Castro; Erika Stefàno; Danilo Migoni; Giorgia N Iaconisi; Antonella Muscella; Santo Marsigliante; Michele Benedetti; Francesco P Fanizzi
Journal:  Pharmaceutics       Date:  2021-04-30       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.